Touch the screen or click to continue...
Checking your browser...
capheat.pages.dev


Dietmar hutmacher biography definition

          Professor Hutmacher's background is a strong combination of academic and industrial....

          Dietmar Hutmacher

          Main Research Areas

          Through a combination of academic and industrial experience, Professor Hutmacher has developed expertise in biomaterials, biomechanics, medical devices, and tissue engineering.

          Regenerative medicine/tissue engineering is a rapidly growing multidisciplinary field involving the life, physical and engineering sciences and seeks to develop functional cell, tissue and organ substitutes to repair, replace or enhance biological function that has been lost due to congenital abnormalities, injury, disease or aging.

          Professor Dietmar W. He is a biomedical engineer who is one of very few academics in the field of biomaterials/tissue engineering to have taken a research.

        1. Professor Dietmar W. He is a biomedical engineer who is one of very few academics in the field of biomaterials/tissue engineering to have taken a research.
        2. Distinguished Professor (& Director Max Planck Queensland Centre (MPQC) for the Materials Science of Extracellular Matrices).
        3. Professor Hutmacher's background is a strong combination of academic and industrial.
        4. Professor and Chair in Regenerative Medicine · Head of Research Domain · Professor & Chair · Associate Professor · Assistant Professor.
        5. Distinguished Professor Dietmar W. Dietmar's research and expertise is in biomaterials, biomechanics, medical devices and tissue engineering.
        6. It includes both the regeneration of tissues in vitro for subsequent implantation in vivo as well as regeneration directly in vivo. In addition to having a therapeutic application, tissue engineering can have a diagnostic application where the engineered tissue is used as a biosensor.

          Engineered tissues can also be used for the development of drugs including screening for novel drug candidates, identifying novel genes as drug target